C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 241/40 (2006.01) A61K 31/498 (2006.01) A61P 35/00 (2006.01) C07D 241/42 (2006.01)
Patent
CA 2442270
The present invention is directed to compounds comprising a 2,3- diphenylquinoxaline moiety such as that of Formula A which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to a chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention. (see formula A)
Cette invention se rapporte à des composés comprenant une fraction 2,3-diphénylquinoxaline qui inhibent l'activité de l'enzyme Akt, une sérine/thréonine protéine kinase. Cette invention concerne en outre des compositions chimiothérapeutiques contenant ces composés et des procédés de traitement du cancer consistant à administrer ces composés.
Barnett Stanley F.
Graham Samuel L.
Remy David C.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Inhibitors of akt activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of akt activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of akt activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1726929